Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinoma using quantitative polymerase chain reaction method

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 8, 1997, Pages 863-867

  Rawnsley, Jeffrey D ^a   Srivatsan, Eri S ^b   Chakrabarti, Rita ^b   Billings, Kathleen R ^a   Wang, Marilene B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE DELETION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

EID: 0030749663     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1997.01900080097012     Document Type: Article

References (14)

1. Parkin D, Laara F, Muir C. Cancer incidence in five continents: comparability and quality of data. Int J Cancer. 1988;41:184-197.
2. Kamb A. Cell cycle regulators and cancer. Trends Genet. 1995;11:136-140.
3. Van der Riet P, Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 1994;54:1156-1158.
4. Serrano M, Hannon GJ, Beach D, et al. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704-707.
5. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264:436-439.
6. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368: 753-756.
7. Mori T, Miura K, Aoki T, Mishihira T, Mori S, Nakamura Y. Frequent somatic mutations of the MTS1/CDK4I gene in esophageal cancer. Cancer Res. 1994;54: 3396-3397.
8. Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T. Higher frequency of alterations in the p16/CDKN1 gene squamous carcinoma lines than in primary tumors of the head and neck. Cancer Res. 1994;54:5050-5053.
9. Srivatsan E, Benedict W, Stanbridge E. Implications of chromosome 11 in suppression of neoplastic expression in human cell hybrids. Cancer Res. 1986;46: 6174-6179.
10. Weissenbach J, Gyapay G, Dib C, et al. A second generation linkage map. Nature. 1992;359:794-801.
11. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer. 1994;9:192-206.
12. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous carcinoma. Cancer Res. 1994;54:1152-1155.
13. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/ INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996; 56:3630-3633.
14. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science. 194;265:415-417.